Remove Clinical Trials Remove Conditions Remove Hemp
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Weekly Legislative Roundup 1/18/19

NORML

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Senator Anna Wishart (D) has re-introduced legislation, LB 110, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

article thumbnail

The Cannabis Cancer Connection

Project CBD

Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer. Goldstrich, MD, with Angela Bacca (Flower Valley Press, 2023).

article thumbnail

What is CBN (Cannabinol)? How does the natural byproduct of THC work?

The Cannigma

Long before THC was discovered in the 1940s , CBN was first identified at the turn of the 20th century from a plant that was then known as Indian hemp. What can the current clinical trials tell us? THC and is extracted from hemp, it’s generally considered legal. As long as the product contains <0.3%

THC 139
article thumbnail

CBD Science Update

Project CBD

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 222
article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. There’s a condition that we call GERD, gastroesophageal reflux disease. Cannabis sativa literally means “useful hemp.” Dr. Weil: Yes, it does.

Medicine 306